stacking tirzepatide with semaglutide Dosing: 0.5mg 3x/Week Protocol (2026) Switching from tirzepatide to semaglutide:

This was published 3 months ago Opinion Its the elephant in the jockeys room

Furthermore, CKD in patients with diabetes is globally the leading cause of end-stage kidney disease and leading to increased health care cost due to renal replacement therapy [4]

Tirzepatide Research# SURPASS program (Type 2 diabetes): Five Phase 3 trials demonstrating superior HbA1c reduction compared to insulin glargine, semaglutide, and insulin degludec SURMOUNT program (Obesity): Phase 3 trials showing up to 20.9% weight loss at 72 weeks FDA approvals : Mounjaro (May 2022) for T2D

Will I Lose the Cardiovascular Benefit During a Break